Ocular side effects of dupilumab-Review article and treatment recommendation by the Committee for Dry Eye and Ocular Surface Diseases of the Austrian Society of Ophthalmology (ÖOG)

Woltsche, N; Aschauer, J; Boldin, I; Garhoefer, G; Kaya-Reindl, S; Moussa, S; Nepp, J; Palkovits, S; Wimmer-Orlowski, E; Horwath-Winter, J

Woltsche, N (通讯作者),Med Univ Graz, Univ Augenklin, Auenbruggerplatz 4, A-8036 Graz, Austria.

SPEKTRUM DER AUGENHEILKUNDE, 2023; ():

Abstract

Dupilumab (Dupixent (R), Sanofi and Regeneron Pharmaceuticals) is a human monoclonal antibody against the interleukin (IL)-4 receptor alpha subunit of......

Full Text Link